X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
ADCOCK INGRAM
Jun-14
ALEMBIC PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs792365-   
Low Rs443264-   
Sales per share (Unadj.) Rs167.0108.7-  
Earnings per share (Unadj.) Rs38.2-27.4-  
Cash flow per share (Unadj.) Rs42.0-22.7-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs84.985.3-  
Shares outstanding (eoy) m188.52168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.72.9 127.7%   
Avg P/E ratio x16.2-11.5 -140.9%  
P/CF ratio (eoy) x14.7-13.9 -106.1%  
Price / Book Value ratio x7.33.7 197.3%  
Dividend payout %10.50-   
Avg Mkt Cap Rs m116,38353,081 219.3%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m4,2143,331 126.5%   
Avg. sales/employee Rs ThNM4,273.4-  
Avg. wages/employee Rs ThNM776.0-  
Avg. net profit/employee Rs ThNM-1,076.8-  
INCOME DATA
Net Sales Rs m31,48718,346 171.6%  
Other income Rs m55128 42.9%   
Total revenues Rs m31,54218,474 170.7%   
Gross profit Rs m10,060-3,179 -316.4%  
Depreciation Rs m722792 91.2%   
Interest Rs m37497 7.4%   
Profit before tax Rs m9,356-4,339 -215.6%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,160271 796.7%   
Profit after tax Rs m7,194-4,623 -155.6%  
Gross profit margin %31.9-17.3 -184.4%  
Effective tax rate %23.1-6.2 -369.5%   
Net profit margin %22.8-25.2 -90.7%  
BALANCE SHEET DATA
Current assets Rs m15,06613,437 112.1%   
Current liabilities Rs m7,6747,560 101.5%   
Net working cap to sales %23.532.0 73.3%  
Current ratio x2.01.8 110.5%  
Inventory Days Days67111 60.4%  
Debtors Days Days41124 32.8%  
Net fixed assets Rs m8,2377,832 105.2%   
Share capital Rs m37785 442.6%   
"Free" reserves Rs m15,4160-   
Net worth Rs m16,00514,399 111.2%   
Long term debt Rs m05,060 0.0%   
Total assets Rs m24,59427,201 90.4%  
Interest coverage x255.2-7.7 -3,301.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.30.7 189.8%   
Return on assets %29.4-15.2 -193.9%  
Return on equity %44.9-32.1 -140.0%  
Return on capital %58.7-19.8 -296.2%  
Exports to sales %55.70-   
Imports to sales %10.40-   
Net fx Rs m12,4930-   
CASH FLOW
From Operations Rs m9,3041,566 594.1%  
From Investments Rs m-3,105-481 645.7%  
From Financial Activity Rs m-1,9594,592 -42.7%  
Net Cashflow Rs m4,2405,678 74.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.04 Rs / ZAR

Compare ALEMBIC PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC PHARMA With: MERCK LTD  AUROBINDO PHARMA  VENUS REMEDIES  FRESENIUS KABI ONCO.  SANOFI INDIA  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jun 22, 2018 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - WOCKHARDT LTD. COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS